(Q43664760)

25 November 2017

Infectious complications in the child with cancer. II. Management of specific infectious organisms (English)

1 reference

25 November 2017

Pizzo PA

1

1 reference

PubMed ID

7205478

25 November 2017

language of work or name

English

0 references

publication date

1 April 1981

1 reference

The Journal of Pediatrics

25 November 2017

1 reference

25 November 2017

98

1 reference

25 November 2017

4

1 reference

25 November 2017

513-523

1 reference

Effects of methotrexate on group A beta hemolytic streptococci and streptococcal infection

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Sepsis with a new species of Corynebacterium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Corynebacterium equiInfection Complicating Neoplastic Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Management of Anaerobic Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Complications of BCG immunotherapy in patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Disseminated bcg disease associated with immunotherapy by scarification in acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Clinical and immunologic studies of disseminated BCG infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Serologic tests in the diagnosis of systemic candidiasis. Enhanced diagnostic accuracy with crossed immunoelectrophoreses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Strategies in the treatment of systemic fungal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Miconazole in the treatment of chronic mucocutaneous candidiasis: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Treatment of chronic oral candidiasis with clotrimazole troches. A controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Hematogenous Candida endophthalmitis--a complication of candidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Pathoradiologic correlation of pulmonary candidiasis in immunosuppressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Successful treatment of aspergillus pneumonia in hematologic neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Phycomycosis complicating leukemia and lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Cryptococcosis in a cancer hospital.Clinical and pathological correlates in forty-six patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Prognostic factors in cryptococcal meningitis. A study in 111 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Fungemia due to Torulopsis glabrata in the compromised host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Torulopsis glabrata infections in patients with cancer. Increasing incidence and relationship to colonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Histoplasmosis in immunosuppressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Fusarium solani infection during treatment for acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Allescheria boydii infections in the immunosuppressed host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Pneumocystis cariniiPneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Parasitologic and Serologic Observations of Infection with Pneumocystis in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Comparison of pentamidine isethionate andtrimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Isolation of the Encysted Form ofToxoplasma gondiifrom Human Skeletal Muscle and Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Toxoplasmosis in the compromised host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Isolation of Latent Herpes Simplex Virus from the Superior Cervical and Vagus Ganglions of Human Beings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Disseminated Herpesvirus hominis infection in a child with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Effect of adenine arabinoside on severe Herpesvirus hominis infections in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Cytomegalovirus infections during acute childhood leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Cytomegaloviremia in children with acute lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Simultaneous infection with multiple herpesviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Increased Pulmonary Superinfections in Cardiac-Transplant Patients Undergoing Primary Cytomegalovirus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Clinical Trials of Immunization with the Towne 125 Strain of Human Cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Zoster immune globulin. A further assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Prophylaxis of varicella in children with neoplastic disease: comparative results with zoster immune plasma and gamma globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Human Leukocyte Interferon in the Treatment of Varicella in Children with Cancer: a Preliminary Controlled Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Live vaccine used to prevent the spread of varicella in children in hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Herpes zoster and varicella infections in children with hodgkin's disease.An analysis of contributing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

A viremic phase for herpes zoster in children with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Interferon, antibody, and other host factors in herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Variable Phenotypic Expression of an X-Linked Recessive Lymphoproliferative Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

A new tumour-derived transforming strain of Epstein–Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Viral hepatitis, type B. Studies on natural history and prevention re-examined

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Hepatitis B in an Oncology Unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Corticosteroid therapy for chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Administration of human fibroblast interferon in chronic hepatitis-B infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Hepatitis B Immune Globulin for Accidental Exposures among Medical Personnel: Final Report of a Multicenter Controlled Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Parenterally transmitted non-A, non-B hepatitis: an epidemic reassessed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Transmission of Non-A, Non-B Hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Transmissible agent in non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Transmission of non-A, non-B hepatitis from man to chimpanzee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

Measles inclusion-body encephalitis in a child with treated acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980752-4

10.1016/S0022-3476(81)80752-4

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference

PubMed ID

7205478